Characteristics of patients with diabetes mellitus type 1 or type 2
| DMT1 . | N (%) . | Age, y . | Sex, M/F (%) . | Disease duration, y . | HbA1c, % . | Chol, mg/dL . | TG, mg/dL . | HT, n (%) . | SM, n (%) . |
|---|---|---|---|---|---|---|---|---|---|
| Type 1 diabetes patients | |||||||||
| FVL-negative | 186 (93) | 48.2 ± 1.1 | 73/113 (39/61) | 24.8 ± 0.9 | 7.3 ± 0.12 | 196.3 ± 3.7 | 84.4 ± 5.7 | 42 (23) | 42 (23) |
| FVL-positive | 14 (7) | 46.8 ± 3.8 | 8/6 (57/43) | 23.0 ± 3.1 | 6.8 ± 0.36 | 187.1 ± 7.5 | 87.5 ± 7.1 | 4 (29) | 2 (14) |
| PAI-1 5/5 | 41 (20) | 47.7 ± 2.6 | 14/27 (34/66) | 22.1 ± 1.3 | 7.4 ± 0.21 | 195.3 ± 7.8 | 81.0 ± 9.7 | 7 (17) | 5 (12) |
| PAI-1 5/4 | 97 (49) | 48.6 ± 1.5 | 45/52 (46/54) | 25.4 ± 1.3 | 7.4 ± 0.18 | 196.6 ± 5.2 | 83.6 ± 6.2 | 28 (29) | 27 (28) |
| PAI-1 4/4 | 62 (31) | 47.6 ± 1.8 | 22/40 (35/65) | 27.2 ± 2.3 | 7.0 ± 0.19 | 194.1 ± 5.8 | 97.7 ± 12.6 | 13 (21) | 17 (27) |
| Type 2 diabetes patients | |||||||||
| FVL-negative | 326 (93) | 65.7 ± 0.6 | 165/161 (51/49) | 14.0 ± 0.5 | 7.3 ± 0.10 | 191.4 ± 2.9 | 166.5 ± 8.3 | 231 (71) | 73 (22) |
| FVL-positive | 24 (7) | 62.5 ± 3.0 | 14/10 (58/42) | 15.6 ± 2.2 | 7.4 ± 0.37 | 189.5 ± 7.5 | 179.2 ± 21.9 | 14 (58) | 3 (13) |
| PAI-1 5/5 | 60 (17) | 66.7 ± 1.2 | 36/24 (60/40) | 13.6 ± 1.0 | 7.2 ± 0.19 | 182.8 ± 7.3 | 187.1 ± 22.3 | 46 (77) | 8 (13) |
| PAI-1 5/4 | 178 (51) | 65.0 ± 0.8 | 90/88 (51/49) | 13.9 ± 0.8 | 7.3 ± 0.14 | 195.0 ± 3.7 | 167.0 ± 11.9 | 121 (68) | 50 (28) |
| PAI-1 4/4 | 112 (32) | 68.6 ± 1.1 | 53/59 (47/53) | 14.9 ± 0.9 | 7.5 ± 0.17 | 189.4 ± 5.1 | 159.0 ± 11.0 | 78 (70) | 18 (16) |
| DMT1 . | N (%) . | Age, y . | Sex, M/F (%) . | Disease duration, y . | HbA1c, % . | Chol, mg/dL . | TG, mg/dL . | HT, n (%) . | SM, n (%) . |
|---|---|---|---|---|---|---|---|---|---|
| Type 1 diabetes patients | |||||||||
| FVL-negative | 186 (93) | 48.2 ± 1.1 | 73/113 (39/61) | 24.8 ± 0.9 | 7.3 ± 0.12 | 196.3 ± 3.7 | 84.4 ± 5.7 | 42 (23) | 42 (23) |
| FVL-positive | 14 (7) | 46.8 ± 3.8 | 8/6 (57/43) | 23.0 ± 3.1 | 6.8 ± 0.36 | 187.1 ± 7.5 | 87.5 ± 7.1 | 4 (29) | 2 (14) |
| PAI-1 5/5 | 41 (20) | 47.7 ± 2.6 | 14/27 (34/66) | 22.1 ± 1.3 | 7.4 ± 0.21 | 195.3 ± 7.8 | 81.0 ± 9.7 | 7 (17) | 5 (12) |
| PAI-1 5/4 | 97 (49) | 48.6 ± 1.5 | 45/52 (46/54) | 25.4 ± 1.3 | 7.4 ± 0.18 | 196.6 ± 5.2 | 83.6 ± 6.2 | 28 (29) | 27 (28) |
| PAI-1 4/4 | 62 (31) | 47.6 ± 1.8 | 22/40 (35/65) | 27.2 ± 2.3 | 7.0 ± 0.19 | 194.1 ± 5.8 | 97.7 ± 12.6 | 13 (21) | 17 (27) |
| Type 2 diabetes patients | |||||||||
| FVL-negative | 326 (93) | 65.7 ± 0.6 | 165/161 (51/49) | 14.0 ± 0.5 | 7.3 ± 0.10 | 191.4 ± 2.9 | 166.5 ± 8.3 | 231 (71) | 73 (22) |
| FVL-positive | 24 (7) | 62.5 ± 3.0 | 14/10 (58/42) | 15.6 ± 2.2 | 7.4 ± 0.37 | 189.5 ± 7.5 | 179.2 ± 21.9 | 14 (58) | 3 (13) |
| PAI-1 5/5 | 60 (17) | 66.7 ± 1.2 | 36/24 (60/40) | 13.6 ± 1.0 | 7.2 ± 0.19 | 182.8 ± 7.3 | 187.1 ± 22.3 | 46 (77) | 8 (13) |
| PAI-1 5/4 | 178 (51) | 65.0 ± 0.8 | 90/88 (51/49) | 13.9 ± 0.8 | 7.3 ± 0.14 | 195.0 ± 3.7 | 167.0 ± 11.9 | 121 (68) | 50 (28) |
| PAI-1 4/4 | 112 (32) | 68.6 ± 1.1 | 53/59 (47/53) | 14.9 ± 0.9 | 7.5 ± 0.17 | 189.4 ± 5.1 | 159.0 ± 11.0 | 78 (70) | 18 (16) |
Means ± SEM are shown for age, disease duration, HbA1c, plasma cholesterin (Chol), and plasma triglycerides (TG). No significant differences between groups were observed.
HT indicates hypertension; and SM, history of smoking.